The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

Bank of America Securities analyst Travis Steed maintained a Buy rating on Boston Scientific (BSX – Research Report) today. The ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

We recently compiled a list of the 8 Hot Growth Stocks To Buy According to Hedge Funds. In this article, we are going to take ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

The American Society for Preventive Cardiology (ASPC) announces a full program of events to be held at their annual Congress on Cardiovascular Disease Prevention, scheduled in 2025 for July 31 – ...

Boston Scientific ( NYSE: BSX) has agreed to acquire privately held medical technology company, Cortex, Inc.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...